Your browser doesn't support javascript.
Protective Effect of Fluvoxamine for COVID-19 in Obsessive-Compulsive Disorder: A Real-World Case-Control Study.
Diaz, Ailyn D; Baweja, Raman.
  • Diaz AD; Pennsylvania State University College of Medicine, Hershey, Pennsylvania.
  • Baweja R; Corresponding author: Ailyn D. Diaz, MD, Pennsylvania State University College of Medicine, 500 University Dr, Hershey, PA 17033 (adiaz@pennstatehealth.psu.edu).
Prim Care Companion CNS Disord ; 24(5)2022 10 06.
Article in English | MEDLINE | ID: covidwho-2066798

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment / Obsessive-Compulsive Disorder Type of study: Experimental Studies / Observational study / Randomized controlled trials Topics: Long Covid Limits: Humans Language: English Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment / Obsessive-Compulsive Disorder Type of study: Experimental Studies / Observational study / Randomized controlled trials Topics: Long Covid Limits: Humans Language: English Year: 2022 Document Type: Article